The groundbreaking rise of Viagra has long been a symbol of pharmaceutical success, however its future within the broader market now triggers questions about potential yields . Generic versions are undercutting patent protection , prompting concerns that betting on companies heavily reliant to Viagra's former position could be a speculative move ,